The innate immune receptor Toll-like receptor 3 (TLR3) can be present on the surface of the plasma membranes of cells and in endolysosomes. The Unc93b1 protein has been reported to facilitate localization of TLR7 and 9 and is required for TLR3, -7, and -9 signaling. We demonstrate that siRNA knockdown of Unc93b1 reduced the abundance of TLR3 on the cell surface without altering total TLR3 accumulation. In addition, siRNA to Unc93b1 reduced the secretion of the TLR3 ectodomain (T3ECD) into the cell medium. Furthermore, two human single nucleotide polymorphisms that affected herpesvirus and influenza virus encephalopathy as well as a natural isoform generated by alternative splicing were found to be impaired for T3ECD secretion and decreased the abundance of TLR3 on the cell surface. The locations of the SNP P554S and the deletion in the isoform led to the identification of a loop in the TLR3 ectodomain that is required for secretion and a second whose presence decreased secretion. Finally, a truncated protein containing the N-terminal 10 leucine-rich repeats of T3ECD was sufficient for secretion in an Unc93b1-dependent manner.Toll-like receptors (TLRs) 2 are a family of receptors that recognize pathogen-associated molecular patterns (PAMPs) and initiate signal transduction pathways to activate innate immune responses and to modulate adaptive immunity responses. There are more than 10 known human TLRs that collectively recognize a remarkable variety of ligands (1). The subcellular location of the different TLRs is related to ligand recognition. TLR3, -7, -8, and -9 recognize nucleic acids in endolysosomal compartments, whereas TLR1, -2, -4, -5, and -6 mainly recognize bacterial products and are located primarily on the cell surface (2-4).TLR3 binds viral double-stranded (ds) RNAs and dsRNA mimics such as poly(I:C), annealed homopolymers of inosinic acid and cytidylic acid. Like other TLRs, TLR3 is a type I transmembrane glycoprotein with a large N-terminal ectodomain (ECD) for ligand binding, a single transmembrane helix, and a C-terminal cytoplasmic Toll-interleukin-1 receptor (TIR) domain. The TLR3 ectodomain (T3ECD) consists of 23 conserved leucine-rich repeats (LRRs) capped at the termini by cysteinerich motifs (5, 6). The T3ECD has 15 predicted N-linked glycosylation sites and two short loops that reside in LRR12 (Loop 1) and LRR20 (Loop 2), respectively (7, 8). The crystal structure of the T3ECD complexed with dsRNA revealed two ligand binding sites, one within the region from LRR19 to LRR21 and the other within the N terminus to LRR3, as well as a dimerization domain in the C-terminal cysteine-rich cap (9, 10).Single nucleotide polymorphisms (SNPs) in TLRs have been correlated with disease conditions such as asthma, endotoxin hyporesponsiveness, sepsis, immunodeficiencies, and atherosclerosis (11-18). For TLR3, SNP P554S within LRR20 is linked with partial penetrance of herpes simplex virus-associated encephalitis in children (19). SNP F303S within LRR11 is linked to pathologies of influenza virus infecti...